NasdaqGS - Nasdaq Real Time Price USD

Erasca, Inc. (ERAS)

1.3900
0.0000
(0.00%)
At close: May 9 at 4:00:00 PM EDT
1.3900
0.00
(0.00%)
After hours: May 9 at 4:05:06 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
157,087
157,087
141,525
145,450
96,538
Operating Income
-157,087
-157,087
-141,525
-145,450
-96,538
Net Non Operating Interest Income Expense
20,093
20,093
16,712
4,902
190
Other Income Expense
-24,656
-24,656
-229
-102,257
-26,416
Pretax Income
-161,650
-161,650
-125,042
-242,805
-122,764
Net Income Common Stockholders
-161,650
-161,650
-125,042
-242,805
-122,764
Diluted NI Available to Com Stockholders
-161,650
-161,650
-125,042
-242,805
-122,764
Basic EPS
-0.79
-0.69
-0.83
-1.99
-1.85
Diluted EPS
-0.79
-0.69
-0.83
-1.99
-1.85
Basic Average Shares
200,701.5040
233,817.9160
150,184.9940
122,024.8480
66,290.5920
Diluted Average Shares
200,701.5040
233,817.9160
150,184.9940
122,024.8480
66,290.5920
Total Operating Income as Reported
-179,587
-179,587
-141,525
-247,450
-124,883
Total Expenses
157,087
157,087
141,525
145,450
96,538
Net Income from Continuing & Discontinued Operation
-161,650
-161,650
-125,042
-242,805
-122,764
Normalized Income
-139,150
-139,150
-125,042
-140,805
-94,419
Interest Income
20,093
20,093
16,712
4,902
190
Net Interest Income
20,093
20,093
16,712
4,902
190
EBIT
-157,087
-157,087
-141,525
-145,450
-96,538
EBITDA
-153,282
-153,282
-137,793
-142,809
-95,709
Reconciled Depreciation
3,805
3,805
3,732
2,641
829
Net Income from Continuing Operation Net Minority Interest
-161,650
-161,650
-125,042
-242,805
-122,764
Total Unusual Items Excluding Goodwill
-22,500
-22,500
0
-102,000
-28,345
Total Unusual Items
-22,500
-22,500
0
-102,000
-28,345
Normalized EBITDA
-130,782
-130,782
-137,793
-40,809
-67,364
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 7/16/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ORIC ORIC Pharmaceuticals, Inc.
5.08
-4.51%
 
BOLD Boundless Bio, Inc.
1.4400
-4.00%
 
RVMD Revolution Medicines, Inc.
40.42
-3.56%
 
TNGX Tango Therapeutics, Inc.
1.1400
+3.64%
 
EWTX Edgewise Therapeutics, Inc.
14.58
-0.82%
 
IDYA IDEAYA Biosciences, Inc.
17.42
-4.18%
 
IRON Disc Medicine, Inc.
44.24
-0.11%
 
NUVL Nuvalent, Inc.
69.85
-2.44%
 
YMAB Y-mAbs Therapeutics, Inc.
3.8900
-3.71%
 
DSGN Design Therapeutics, Inc.
3.5000
-0.57%